metformin has been researched along with Flatus in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Excerpt | Relevance | Reference |
---|---|---|
" Another patient on acarbose developed severe hypoglycemia; glycemic control was subsequently maintained on half the baseline dosage of sulfonylurea." | 2.69 | Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo-controlled study. ( Ip, TP; Lam, KS; Tam, SC; Tiu, SC; Tsang, MW, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wolever, TM | 1 |
Radmard, R | 1 |
Chiasson, JL | 1 |
Hunt, JA | 1 |
Josse, RG | 1 |
Palmason, C | 1 |
Rodger, NW | 1 |
Ross, SA | 1 |
Ryan, EA | 1 |
Tan, MH | 1 |
Lam, KS | 1 |
Tiu, SC | 1 |
Tsang, MW | 1 |
Ip, TP | 1 |
Tam, SC | 1 |
2 trials available for metformin and Flatus
Article | Year |
---|---|
One-year acarbose treatment raises fasting serum acetate in diabetic patients.
Topics: Acarbose; Acetates; Body Mass Index; Cholesterol; Diabetes Mellitus, Type 2; Diet, Diabetic; Double- | 1995 |
Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo-controlled study.
Topics: Acarbose; Administration, Oral; Blood Glucose; China; Cholesterol; Cholesterol, HDL; Diabetes Mellit | 1998 |